Literature DB >> 26861901

Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.

Romuald Girard1, Omaditya Khanna1, Robert Shenkar1, Lingjiao Zhang1, Meijing Wu1, Michael Jesselson1, Hussein A Zeineddine1, Anupriya Gangal1, Maged D Fam1, Christopher C Gibson2, Kevin J Whitehead3, Dean Y Li3, James K Liao4, Changbin Shi1, Issam A Awad1.   

Abstract

AIM: To correlate cerebral cavernous malformations (CCMs) disease aggressiveness with peripheral blood biomarkers hypothesized mechanistically. PATIENTS &
METHODS: A prospective case-control study enrolled 43 CCM patients, where 25-(OH) vitamin D, HDL and non-HDL cholesterol, CRP plasma levels and leukocyte ROCK activity were correlated with parameters of disease aggressiveness reflecting chronic and acute domains.
RESULTS: Patients with one or more features of chronically aggressive disease (early age at symptom onset, two or more symptomatic bleeds, high lesion burden) had significantly lower 25-(OH) vitamin D and non-HDL cholesterol levels in comparison to patients without these features.
CONCLUSION: Validation of these biomarkers and their potential treatment modulation may influence the clinical care of patients with CCM disease.

Entities:  

Keywords:  aggressiveness; biomarker; cerebral cavernous malformation; inflammation; non-HDL cholesterol; vitamin D

Mesh:

Substances:

Year:  2016        PMID: 26861901      PMCID: PMC4926533          DOI: 10.2217/bmm.15.118

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  36 in total

1.  Prospective hemorrhage risk of intracerebral cavernous malformations.

Authors:  K D Flemming; M J Link; T J H Christianson; R D Brown
Journal:  Neurology       Date:  2012-02-01       Impact factor: 9.910

Review 2.  Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.

Authors:  Jamie Robertson; Mike J Peters; Iain B McInnes; Naveed Sattar
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

3.  Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges.

Authors:  Salim S Virani
Journal:  Tex Heart Inst J       Date:  2011

4.  A global representation of vitamin D status in healthy populations.

Authors:  D A Wahl; C Cooper; P R Ebeling; M Eggersdorfer; J Hilger; K Hoffmann; R Josse; J A Kanis; A Mithal; D D Pierroz; J Stenmark; E Stöcklin; B Dawson-Hughes
Journal:  Arch Osteoporos       Date:  2012-08-29       Impact factor: 2.617

Review 5.  [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies].

Authors:  P Otten; G P Pizzolato; B Rilliet; J Berney
Journal:  Neurochirurgie       Date:  1989       Impact factor: 1.553

6.  Natural history and imaging prevalence of cavernous malformations in children and young adults.

Authors:  Wajd N Al-Holou; Thomas M O'Lynnger; Aditya S Pandey; Joseph J Gemmete; B Gregory Thompson; Karin M Muraszko; Hugh J L Garton; Cormac O Maher
Journal:  J Neurosurg Pediatr       Date:  2012-02       Impact factor: 2.375

7.  Aggressive course of multiple de novo cavernous malformations.

Authors:  Kelly D Flemming; George K Bovis; Fredric B Meyer
Journal:  J Neurosurg       Date:  2011-09-09       Impact factor: 5.115

Review 8.  Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling.

Authors:  Bryan T Richardson; Christopher F Dibble; Asya L Borikova; Gary L Johnson
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

Review 9.  A systematic review of vitamin D status in populations worldwide.

Authors:  Jennifer Hilger; Angelika Friedel; Raphael Herr; Tamara Rausch; Franz Roos; Denys A Wahl; Dominique D Pierroz; Peter Weber; Kristina Hoffmann
Journal:  Br J Nutr       Date:  2013-08-09       Impact factor: 3.718

10.  Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.

Authors:  Robert Shenkar; Changbin Shi; Douglas A Marchuk; Issam A Awad; Tania Rebeiz; Rebecca A Stockton; David A McDonald; Abdul Ghani Mikati; Lingjiao Zhang; Cecilia Austin; Amy L Akers; Carol J Gallione; Autumn Rorrer; Murat Gunel; Wang Min; Jorge Marcondes De Souza; Connie Lee
Journal:  Genet Med       Date:  2014-08-14       Impact factor: 8.822

View more
  14 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.

Authors:  Romuald Girard; Maged D Fam; Hussein A Zeineddine; Huan Tan; Abdul Ghani Mikati; Changbin Shi; Michael Jesselson; Robert Shenkar; Meijing Wu; Ying Cao; Nicholas Hobson; Henrik B W Larsson; Gregory A Christoforidis; Issam A Awad
Journal:  J Neurosurg       Date:  2016-08-05       Impact factor: 5.115

3.  Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.

Authors:  Romuald Girard; Hussein A Zeineddine; Maged D Fam; Anoop Mayampurath; Ying Cao; Changbin Shi; Robert Shenkar; Sean P Polster; Michael Jesselson; Ryan Duggan; Abdul-Ghani Mikati; Gregory Christoforidis; Jorge Andrade; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Transl Stroke Res       Date:  2017-08-17       Impact factor: 6.829

4.  Vitamin D levels are associated with epistaxis severity and bleeding duration in hereditary hemorrhagic telangiectasia.

Authors:  Lauren Marissa Weber; Jamie McDonald; Kevin Whitehead
Journal:  Biomark Med       Date:  2018-03-14       Impact factor: 2.851

5.  Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).

Authors:  Sean P Polster; Ying Cao; Timothy Carroll; Kelly Flemming; Romuald Girard; Daniel Hanley; Nicholas Hobson; Helen Kim; James Koenig; Janne Koskimäki; Karen Lane; Jennifer J Majersik; Nichol McBee; Leslie Morrison; Robert Shenkar; Agnieszka Stadnik; Richard E Thompson; Joseph Zabramski; Hussein A Zeineddine; Issam A Awad
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

Review 6.  Familial Cerebral Cavernous Malformations.

Authors:  Atif Zafar; Syed A Quadri; Mudassir Farooqui; Asad Ikram; Myranda Robinson; Blaine L Hart; Marc C Mabray; Catherine Vigil; Alan T Tang; Mark L Kahn; Howard Yonas; Michael T Lawton; Helen Kim; Leslie Morrison
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

7.  Biomarkers of cavernous angioma with symptomatic hemorrhage.

Authors:  Seán B Lyne; Romuald Girard; Janne Koskimäki; Hussein A Zeineddine; Dongdong Zhang; Ying Cao; Yan Li; Agnieszka Stadnik; Thomas Moore; Rhonda Lightle; Changbin Shi; Robert Shenkar; Julián Carrión-Penagos; Sean P Polster; Sharbel Romanos; Amy Akers; Miguel Lopez-Ramirez; Kevin J Whitehead; Mark L Kahn; Mark H Ginsberg; Douglas A Marchuk; Issam A Awad
Journal:  JCI Insight       Date:  2019-06-20

8.  Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.

Authors:  Romuald Girard; Hussein A Zeineddine; Janne Koskimäki; Maged D Fam; Ying Cao; Changbin Shi; Thomas Moore; Rhonda Lightle; Agnieszka Stadnik; Kiranj Chaudagar; Sean Polster; Robert Shenkar; Ryan Duggan; David Leclerc; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Circ Res       Date:  2018-05-02       Impact factor: 17.367

9.  A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).

Authors:  Romuald Girard; Yan Li; Agnieszka Stadnik; Robert Shenkar; Nicholas Hobson; Sharbel Romanos; Abhinav Srinath; Thomas Moore; Rhonda Lightle; Abdallah Shkoukani; Amy Akers; Timothy Carroll; Gregory A Christoforidis; James I Koenig; Cornelia Lee; Kristina Piedad; Steven M Greenberg; Helen Kim; Kelly D Flemming; Yuan Ji; Issam A Awad
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

Review 10.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.